fda compounding semaglutide crackdown news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our September 2, 2025: U.S. compounding

Instead of following the standard titration schedule, where you increase your dose every four weeks until you hit the high maintenance level, microdosers stay at the lowest effective dose for months, or even take less than the starting dose

Retatrutide, however, wont be on the market until it completes Phase 3 and earns FDA approval

These factors make India a strategic hub for both domestic demand and global generic drug supply

Weight loss, insurance covers: $25-$150/mo copay

Evening injection also offers a social advantage that morning dosing does not

Being more careful and steadier with the needle seems to have helped